The human leukocyte antigen-A2 (HLA-A2)-restricted zinc transporter 8 [186][187][188][189][190][191][192][193][194] + T cells circulate in most individuals but home to the pancreas preferentially in T1D patients. We conclude that the activation of this common islet-reactive T cell repertoire and progression to T1D likely require defective peripheral immunoregulation and/or a proinflammatory islet microenvironment.
INTRODUCTION
In the setting of type 1 diabetes (T1D), insulitic lesions are enriched for CD8 + T cells, which are held as the final mediators of islet destruction. Concordantly, preproinsulin (PPI)-reactive CD8 + T cell clones can lyse  cells in vitro (1) , and  cell-reactive CD8 + T cells infiltrate the islets of T1D patients (2) . Autoimmune CD8 + T cells may therefore provide biomarkers for disease staging complementary to autoantibodies (aAbs).
Although interferon- (IFN-)-secreting CD8
+ T cells detected by enzyme-linked immunospot (ELISpot) distinguish T1D patients from healthy donors (3), the situation is more complex when nonfunctional human leukocyte antigen (HLA) class I multimer (MMr) assays are used. Although MMr + CD8 + T cells were often (4), but not invariably (5, 6) , found at similar frequencies in both T1D and healthy individuals, they have been reported to exhibit more differentiated effector/memory phenotypes (4, 6) in T1D patients. A rather enigmatic state of "benign" autoimmunity therefore exists in healthy individuals.
To extend these observations, we aimed to determine the key features of islet-reactive CD8 + T cells that associate with T1D. We focused our efforts on immunodominant HLA-A*02:01 (HLA-A2)-restricted epitopes derived from PPI, glutamic acid decarboxylase (GAD), insulinoma-associated protein-2 (IA-2), and islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) (3) , and on a highly immunoprevalent zinc transporter 8 [186] [187] [188] [189] [190] [191] [192] [193] [194] (ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] ) epitope that we recently described (7) . The results indicate that incomplete central tolerance mechanisms allow the survival of an isletreactive CD8 + T cell repertoire, which can be primed in the presence of defective peripheral immunoregulation and/or a proinflammatory islet microenvironment to progress toward T1D.
RESULTS

ZnT8 186-194 -reactive CD8
+ T cell clones from T1D and healthy donors display equivalent functionality Given that ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] -reactive IFN- responses are highly prevalent in T1D patients (7), we started by generating ZnT8 186-194 -reactive ZnT8 186-194 -reactive CD8 + T cell clones from T1D and healthy donors display equivalent  cell cytotoxicity To determine whether ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] -reactive CD8 + T cells can recognize naturally processed ZnT8 epitopes, we performed cytotoxicity assays using ZnT8-transduced K562-A2 targets (K562-A2/ZnT8). High-avidity ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] -reactive clones lysed unpulsed K562-A2/ZnT8 targets almost as efficiently as targets pulsed with the ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] peptide, whereas unpulsed K562-A2 control targets remained largely intact (Fig. 3, A and B) . In contrast, low-avidity ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] -reactive clones were unable to lyse K562-A2/ZnT8 targets in the absence of exogenous ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] peptide (Fig. 3C) .
We then evaluated cytotoxicity against T1D-relevant targets by using HLA-A2 + ECN90 and control HLA-A2 − EndoC-H2 human  cell lines. Although the ECN90 but not the EndoC-H2 line expressed HLA class I in the unstimulated state, expression levels were similarly up-regulated by pretreatment with different cocktails of inflammatory cytokines, without inducing significant  cell death ( fig. S4 , A and B). IFN- was chosen as the single cytokine that up-regulated HLA class I expression to comparable levels in both lines, and pretreatment was carried out for 18 hours before a real-time cytotoxicity assay. As observed with K562-A2/ZnT8 targets, high-avidity clones lysed unpulsed HLA-A2 + ECN90 cells presenting naturally processed ZnT8-derived epitopes (Fig. 3 , D and E), whereas low-avidity clones displayed marginal lytic activity (Fig. 3F) . Cytotoxicity increased in all cases with the addition of the ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] peptide, suggesting a more limited natural presentation compared with ZnT8-transduced targets. Lysis of HLA-A2 − EndoC-H2 cells was negligible, and a control clone reactive to the melanocyte self-epitope MelanA [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] only lysed ECN90 cells in the presence of exogenous MelanA [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] peptide (Fig. 3G ). Microscopic inspection confirmed the lysis measured in real-time cytotoxicity assays ( fig. S4C ).  cell lysis was not different between T1D and healthy clones, either in the absence or in the presence of exogenous ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] peptide (Fig. 3H) . Moreover, IFN- pretreatment of HLA-A2 + ECN90 cells neither up-regulated ZnT8 protein expression ( fig. S4D ) nor increased the functional activation of co-incubated CD8 + T cell clones (fig. S4, E and F). Collectively, these results demonstrate that ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] -reactive CD8 + T cells display similar cytotoxicity in T1D and healthy individuals and that ZnT8 expression is not modulated by inflammation.
+ T cells display private TCR gene usage but public CDR3 amino acid sequences Molecular analysis of expressed TCR (TRA) and TCR (TRB) gene transcripts revealed that no sequences were shared (public) among ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] -reactive clones isolated from T1D or healthy individuals ( fig. S5 ). The three clones from patient D222D harbored an identical TCR. However, this observation did not affect our previous functional comparisons because the measured parameters were even more similar between T1D and healthy donors when only one D222D clone was considered.
We then interrogated an in silico database of TRB sequences compiled by high-throughput sequencing of naïve/terminal effector (CD45RA CDR3 loops to generate "mosaic" sequences. The same CDR3 amino acid sequences were detected in silico among the polyclonal TCR repertoires compiled from conventional and regulatory CD4 + and CD8 + T cells isolated from pancreatic lymph node (PLN) and spleen samples by the Network for Pancreatic Organ Donors with Diabetes (nPOD) (n = 67 identical CDR3; n = 6 identical TCR; Fig. 4D ). Most of the CD8 + T cell hits in PLNs (11 of 15, 73%) were from HLA-A2 + patients but with no obvious association with T1D.
To extend these findings, we developed D010R 1E2, H328C 8E8, and D222D TRA and TRB clonotype-specific TaqMan real-time quantitative PCR (qPCR) assays ( fig. S6, A and B) . Applied to CD4 + and CD8 + T cell complementary DNA (cDNA) preparations from two independent cohorts of T1D patients (n = 97 and n = 53) and healthy individuals (n = 97 and n = 38), these assays detected the D010R and H328C (Fig. 5D ). An exception was noted for PPI [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] -reactive CD8 + T cells, whose frequencies were lower than those for other  cellreactive fractions and higher in T1D versus healthy donors. In all instances, the Ag-experienced fraction among MMr + CD8
+ T cells was limited in both subject groups (Fig. 5, E and F) . The few children included in this extended analysis harbored  cell-reactive CD8 + T cells with a more Ag-experienced phenotype. CD45RA + CCR7
+ islet-reactive cells were bona fide naïve because they were largely CD27 +
CD28
+ and CD95 − ( fig. S11 ). Collectively, these results show that circulating CD8 + T cells reactive to ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] and other  cell epitopes occur at similar frequencies and exhibit a predominantly naïve phenotype in T1D and healthy adults, whereas higher frequencies of total and Ag-experienced ZnT8 186-194 -reactive CD8 + T cells are present in children, irrespective of T1D status.
Poor promiscuous ZnT8 gene expression in human thymic medullary epithelial cells
The combined observations that CD8 + T cells reactive to ZnT8 186-194 and other  cell epitopes are predominantly naïve and circulate at similar frequencies in T1D and healthy donors are compatible with frequent escape from thymic deletion due to poor islet Ag expression in thymic medullary epithelial cells (mTECs) (14) . We tested this hypothesis by examining ZnT8 (SLC30A8) gene expression in total or immature (AIRE human mTECs from five children undergoing heart surgery. As misinitiated mRNA transcription is described in mTECs (13, 15) , forward primers were designed to identify potential alternative start sites via hybridization with exons 5 to 8 of the SLC30A8 gene (Fig. 6A) . The ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] region is encoded by exons 7 and 8, with the exon 8 primer located just downstream. Combinations of these forward primers with reverse primers located either in exon 11 (Fig. 6B ) or in the 3′ untranslated region (3′UTR) (Fig. 6C) (Fig. 6, D and E) . In conjunction with the finding that circulating CD8 + T cells reactive to ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] and other islet epitopes also occur at similar frequencies (Fig. 5D ), these observations suggest a limited role of thymic Ag gene expression in setting such frequencies.
Potential confounders in this scenario include the efficiency of epitope presentation and the odds of encountering cognate peptide-HLA complexes in the thymic environment. Accordingly, we compared the frequencies of islet-reactive CD8 + T cells in age-and sex-matched HLA-A2 + and HLA-A2 − healthy adults, reasoning that thymic deletion cannot occur in the absence of the appropriate HLA-A2 restriction (21) . To exclude promiscuous presentation by non-HLA-A2 molecules, we selected donors based on HLA-A and HLA-B molecules incapable of binding the selected islet epitopes (table S4) . Moreover, all patients were seronegative for Ebola (EboV) and hepatitis C virus (HCV). Representative flow cytometry plots are shown in fig. S12 . Except for PPI [6] [7] [8] [9] [10] [11] [12] [13] [14] , HLA-A2-restricted islet-reactive CD8 + T cells occurred at largely equivalent frequencies in HLA-A2 + and HLA-A2 − donors (Fig. 6F) . Although higher overall relative to most islet specificities, the frequencies of MMr + CD8 + cells recognizing the HLA-A2-restricted foreign epitopes EboV NP 202-210 and HCV PP 1406-1415 were also similar between HLA-A2 + and HLA-A2 − groups. No significant phenotypic differences were observed between groups for any of these MMr + CD8 + T cell populations (Fig. 6G ). As expected, control Flu MP 58-66 MMr + CD8
+ cells were more prevalent and more Ag-experienced in HLA-A2 + donors. Collectively, these findings suggest that thymic presentation of these islet epitopes does not trigger significant clonal deletion in HLA-A2 + donors.
ZnT8 186-194 -reactive CD8 + T cells cross-recognize a Bacteroides stercoris mimotope Although islet-reactive CD8
+ T cells were predominantly naïve in T1D and healthy adults, substantial Ag-experienced fractions were noted in some individuals, irrespective of disease status (Fig. 5, B and E) . + T cells were present at similar frequencies in duplicate samples (Fig. 7C) . Cross-reactivity with the B. stercoris mimotope was confirmed for one of four ZnT8 186-194 -reactive CD8 + T cell clones via MMr costaining (Fig. 7D ) and in vitro recall (Fig. 7E), with 
ZnT8 186-194 -reactive cells are enriched in the pancreas of T1D patients
To reconcile the finding that equivalent frequencies of predominantly naïve islet-reactive CD8 + T cells circulate in most individuals, we hypothesized that the T1D-relevant fraction may be sequestered in the pancreas. We therefore performed in situ ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] MMr staining on frozen pancreatic sections from HLA-A2 + T1D (n = 9), aAb + (n = 9), nondiabetic (n = 11), and type 2 diabetes (T2D) cases (n = 3) from nPOD (table S5) . Representative images are shown in Fig. 8 [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] MMrs, which, in conjunction with positive control vitiligo skin sections, confirmed staining specificity (Fig. 8F) . Donor-matched PLN sections were stained in parallel (Fig. 8, G and H) . Whereas ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] MMr + cells were significantly more abundant than MelanA [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] MMr + cells in T1D, aAb + , and nondiabetic cases, ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] MMr + cells were enriched in the pancreata of T1D versus nondiabetic and T2D cases (Fig. 8I) . In contrast, ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] MMr + cells were present at similar densities across all groups in PLN sections (Fig. 8J) . Several of these nPOD cases were previously analyzed in silico for the presence of ZnT8 186-194 CDR3 sequences in PLNs (Fig. 4D) . These sequences were present in four of five cases with ZnT8 MMr + pancreata and three of five cases with ZnT8 MMr + PLNs (table S5) . A donor with chronic pancreatitis (#6288) and very high ZnT8 186-194 -reactive CD3R counts among spleen and PLN CD8 + T cells also displayed high densities of ZnT8 MMr + cells in the pancreas. Collectively, these results show that ZnT8-reactive cells are preferentially enriched in the pancreas of T1D patients.
DISCUSSION
In this study, we found that ZnT8 186-194 -reactive CD8 + T cell clones exhibited heterogeneous functional profiles but no consistent differences between T1D and healthy individuals. Most ZnT8 186-194 -reactive clones originated from naïve precursors and expressed private TCRs. Ex vivo analyses on larger donor cohorts revealed that the frequency of circulating ZnT8 186-194 -reactive CD8 + T cells was similar in agematched T1D versus healthy donors, but higher in children versus adults, irrespective of T1D status. A similar pattern was noted for CD8 + T cells recognizing the extrapancreatic self-epitope MelanA [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , but the corresponding ZnT8 186-194 -reactive populations were more Agexperienced in T1D children. Thus, although most children harbor a larger autoimmune repertoire not restricted to islet Ags, the activation of the islet-reactive fraction occurs preferentially in T1D children, which may reflect a more aggressive islet autoimmunity leading to earlier disease onset. On the other hand, some Ag-experienced  cell-reactive [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] or no peptide.
CD8
+ T cells were invariably detected in healthy donors, supporting the possibility that foreign epitopes may prime autoreactive clonotypes expressing promiscuous TCRs (22) (23) (24) . Some ZnT8 186-194 -reactive CD8 + T cell clonotypes were able to crossrecognize a B. stercoris mimotope. B. stercoris belongs to the Bacteroidetes phylum, which is enriched in the gut microbiome of T1D (25) and at-risk aAb + individuals (26) . Circulating CD8 + T cells reactive to other HLA-A2-restricted  cell epitopes were also detected at equivalent frequencies (1 to 50 MMr + cells per 10 6 CD8 + T cells) and with a predominantly naïve phenotype in T1D and healthy adults. This coherent pattern across islet specificities suggests that Ag-driven recruitment involves a limited fraction of naïve precursors, which fits with the paucity of public clonotypes found for ZnT8 186-194 -reactive CD8 + T cells, as reported for PPI [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] (4) . The lower frequencies of Flu-reactive CD8 + T cells observed in T1D versus healthy donors may reflect impaired antiviral responses (27) .
One strength of our ex vivo studies is the highly specific and reproducible quantification of MMr + cells. The observed frequencies of  cell-reactive CD8 + T cells fall below previous estimates obtained without enrichment (4, 5) but mirror those described using stringent MMr-based magnetic enrichment (22) . Although higher frequencies of  cell-reactive CD8 + T cells have been observed in T1D versus healthy donors (5), our data align with another study reporting no difference, both with and without dasatinib enhancement of MMr staining (4) . Although the T1D children in our cohort had a longer disease duration than T1D adults, comparable agerelated differences were observed in healthy donors, and similar trends remained when restricting the analysis to more recently diagnosed T1D children. Other studies reporting higher Ag-experienced  cell-reactive * * ** ** * MelanA [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] V V n = 9 n = 3 n = 11 n = 9 n = 9 n = 3 n = 11 n = 7 CD8 + T cell fractions in T1D versus healthy donors are potentially limited by undersampling and single MMr labeling (4) . Moreover, such differences were not observed for all islet epitopes (4), and significant naïve fractions (~40%) were also present in T1D patients (4, 6) .
T cell precursors can escape thymic negative selection due to "blind spots" that result from poor or incomplete expression of certain tissue Ags (13, 17, (28) (29) (30) , due to alternative splicing and promoter usage and misinitiated transcription (13-15, 30) . These features favor the generation of truncated transcripts lacking certain T cell epitopes, as observed for ZnT8. However, ZnT8 186-194 -reactive CD8 + T cells circulated at similar frequencies relative to other islet-reactive populations. Together with the finding that HLA-A2-restricted islet-reactive CD8 + T cells circulated at similar frequencies in HLA-A2 + and HLA-A2 − donors, these results show that the thymus does not eliminate all autoreactive CD8 + T cells. Nonetheless, thymic self-Ag expression may "prune" autoreactive clonotypes bearing high-affinity TCRs (22, 31) .
Perhaps the most outstanding question raised by our findings relates to the benign state of islet autoimmunity "licensed" by incomplete central tolerance. Evidence for such thymic defects in human T1D has been limited to INS polymorphisms, which rank second among T1D susceptibility loci after DQB1 and modulate thymic INS expression (16) . Given the ongoing debate surrounding the role of thymic negative selection for autoreactive T cells (22, 32, 33) , it is not altogether unexpected that even this insulin paradigm does not fully explain T1D development. Homozygous INS susceptibility alleles are present in ~55% of Caucasians (34) , yet very few develop T1D. We propose that incomplete clonal deletion of autoreactive T cells involves several other  cell Ags besides insulin and is not restricted to T1D patients.
So what distinguishes benign from pathogenic autoimmune T cells? The evidence suggests that neither their blood frequency nor their phenotype is at play. However, naïve T cells circulate perpetually, in contrast to memory T cells. The body load of Ag-experienced autoreactive T cells may therefore be underestimated in the blood of diseased individuals due to tissue sequestration (35) . In line with this, the number of ZnT8 186-194 -reactive cells was higher than that of MelanA [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] -reactive ones in the pancreas, similar between aAb + and nondiabetic donors, and enriched in the pancreas of T1D patients. Moreover, ZnT8 186-194 -reactive CD8 + T cell clones displayed potent lytic activity, much higher than other islet specificities (1) . Although these findings suggest a pathogenic role for ZnT8-reactive CD8 + T cells, their precise localization and Ag-experienced status within the pancreas and whether their numbers are inversely correlated with age, as observed in the blood, remain to be verified.
The second possibility is that autoimmune T cells may be differentially regulated in T1D and healthy donors (33, 36) , either intrinsically (e.g., anergy or exhaustion) or extrinsically by regulatory T cells. In support of this notion, T1D-specific islet-reactive CD8 + T cells have been repeatedly detected using functional IFN- ELISpot read outs (3, 7, 10) , which use unfractionated PBMCs, thus preserving regulatory networks. This observation also argues that peripheral blood can be informative under appropriate assay conditions. ZnT8 186-194 -reactive CD8 + T cells from T1D patients also expressed higher levels of aurora A kinase, which might hint at increased mitotic activity in the T1D setting. Mirroring this observation, an anergic phenotype has been reported for self-reactive CD8 + T cells in nonautoimmune patients (22, 36) , which may be at least partially imprinted in the thymus (33, 37) .
The third possibility is that the central diabetogenic ingredient may be enhanced  cell vulnerability caused by islet inflammation in the face of similar autoimmune T cell repertoires across individuals. In this scenario, tolerance to  cell Ags may depend primarily on T cell ignorance (32, 37) . Three observations are noteworthy in this respect. First, the higher T1D risk at younger age contrasts with the lower risk of other autoimmune diseases, which may indicate greater  cell vulnerability due to childhood stressors, such as islet-tropic enteroviruses and the metabolic demands imposed by growth. Second, high densities of ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] MMr + cells were detected in the pancreas of an organ donor with chronic pancreatitis, suggesting that islet-reactive CD8 + T cells can expand under inflammatory conditions that are not autoimmune ab initio. Third, PPI [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] -reactive CD8 + T cells were more frequent in T1D versus healthy donors, with similar results reported for PPI 2-10 (22) . These epitopes map to the PPI leader sequence, which may undergo enhanced processing and presentation under metabolic stress (1) . Collectively, the present data pose new challenges toward development of circulating T cell biomarkers for T1D staging and suggest novel therapeutic strategies based on mimicking benign autoimmunity or complementing incomplete central tolerance (38) .
MATERIALS AND METHODS
Study design
The objective of this study was to identify the features of islet-reactive CD8 + T cells that associate with T1D. Hypotheses were formulated on a prospective basis guided by the data. On the basis of a detailed analysis of ZnT8 186-194 -reactive CD8 + T cell clones (listed in table S1), we initially hypothesized that peripheral autoreactivity occurs independently of disease status. This hypothesis was substantiated using HLA-A2 MMrs to quantify and characterize islet-reactive CD8 + T cells directly ex vivo (donors listed in table S3). Next, we hypothesized that this widespread autoimmune repertoire stems from a universal leakiness of central tolerance, which was verified by thymic gene expression studies and by comparing HLA-A2-restricted Ag-reactive CD8 + T cell population frequencies in HLA-A2 + versus HLAA2 − donors (listed in table S4). Last, we hypothesized that the lack of distinguishing features in the periphery reflects sequestration of the disease-relevant subset in the pancreas. This hypothesis was confirmed by in situ MMr staining of pancreatic sections (donors listed in table S5). After power analysis, age-and sex-matched, unblinded case-control sets were selected from donors recruited at affiliated Diabetology Units. Samples were processed in batch, and no outliers were excluded. All in vitro experiments were performed on at least two separate occasions. For ex vivo MMr analyses, undersampled data points were excluded, as detailed in Figs. 5 and 6. [1406] [1407] [1408] [1409] [1410] [1411] [1412] [1413] [1414] [1415] (KLVALGINAV) were synthesized at >85% purity (ChinaPeptides). Peptide-HLA-A2 affinity and stability assays were performed as detailed in fig. S2 . HLA-A2 MMrs were produced as described (39) , and staining was performed in the presence of 50 nM dasatinib (11) . For Fig. 2B , MMr median fluorescence intensities (MFIs) were normalized to that of D222D clone 2 in the presence of dasatinib.
Study approval
Cloning of ZnT8 186-194 -reactive CD8
+ T cells Frozen-thawed PBMCs (2 × 10 6 to 10 × 10 6 ) were stained with dual fluorochrome-labeled ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] MMrs, either directly ex vivo or after 10 days of acDC culture (8) in the absence or presence of 1 M peptide (ZnT8 [186] [187] [188] [189] [190] [191] [192] [193] [194] or ZnT8 [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] ). Double-positive events were then sorted as single cells into individual wells of a U-bottom 96-well plate. Each sort well contained 200,000 irradiated PBMCs, 5% Cellkines (ZeptoMetrix), proleukin (200 IU/ml), IL-15 (25 ng/ml), phytohemagglutinin-L (PHA-L) (1 g/ml; Sigma-Aldrich), penicillin/ streptomycin, and amphotericin B. Medium was replenished every 3 days without PHA-L. Expanding clones were selected by visual inspection, transferred into 48-well plates for specificity testing, and restimulated as above every 2 to 3 weeks.
Ag recall assays
Peptide-pulsed HLA-A2 + LCLs or K562 cells transduced with HLA-A2, CD80, and 4-1BBL (a gift from J. Riley, University of Pennsylvania, Philadelphia, PA) were labeled with CellTrace Violet (Life Technologies) and incubated with T cells at an E/T ratio of 2:1 for 6 hours in the presence of brefeldin A (10 g/ml). Intracellular cytokine staining was performed using BD Cytofix/Cytoperm reagents and analyzed using a BD LSR Fortessa cytometer. CD107a staining was performed with a fluorescein isothiocyanate-labeled mAb (clone H4A3, BD). Polyfunctionality indices were calculated as described (12) .
Cytotoxicity assays LCL, K562-A2, or K562-A2/ZnT8 target cells were labeled with CellTrace FarRed (Life Technologies), dispensed into 96-well flat-bottom plates at 10 5 cells per well, and cocultured with different numbers of carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled T cells for 6 to 24 hours. After staining with Live/Dead Aqua (Life Technologies) and fixation, a set number of CompBeads (BD) was added to each well. Flow cytometric analysis was performed by counting the numbers of CFSE − FarRed + Live/Dead − targets for each condition, normalized to equal numbers of CompBeads. Percent lysis was calculated as 100 × (live targets cultured alone) − (live targets in the presence of T cells)/(live targets cultured alone). Blocking experiments were conducted with concanamycin A (100 nM; Sigma-Aldrich), brefeldin A (5 g/ml; Sigma-Aldrich), and the anti-FasL antibody NOK-1 (5 g/ml; BD).
The EndoC-H2 cell line (HLA-A*01/03, HLA-B*07/08, and HLA-C*07/07) was described previously (40) , and the ECN90 cell line (HLA-A*02:01/03, HLA-B*40/49, and HLA-C*03/07) was derived from a human neonatal pancreas using similar protocols. Realtime cytotoxicity assays on  cell lines were performed using the xCELLigence system (ACEA Biosciences). Briefly,  cells were dispensed into 96-well E-plates and pretreated as indicated. After resting for 20 hours and pulsing with 10 M peptide or dimethyl sulfoxide for 2 hours, T cells were added at an E/T ratio of 2:1, and impedance was recorded every 5 to 15 min for 4 hours. Cell indices were normalized to values at the time of T cell addition (t = 0) and transformed to percent lysis. TCR sequencing, in silico analyses, and clonotype-specific TaqMan assays TRA and TRB gene expression was analyzed using a template-switch anchored reverse transcription PCR (RT-PCR) (41) for T cell clones and a multiplex nested PCR (42) for single-sorted cells. Gene usage was determined according to the ImMunoGeneTics nomenclature.
The TRB database (Adaptive Biotechnologies) used for in silico analyses was derived from the donors listed in . cDNA samples were amplified using clonotype-specific TaqMan primers for 18 cycles, followed by real-time qPCR using clonotype-specific TaqMan assays on Fluidigm 96.96 microfluidic chips with a BioMark HD qPCR system. Amplification curves for individual assays were examined and compared with curves from a TRB constant region assay as a control for TRB templates in each reaction.
Ex vivo analysis of ZnT8 186-194 -reactive CD8
+ T cells Cryopreserved PBMCs from T1D and healthy donors (table S3) were magnetically depleted of CD8 − cells (STEMCELL Technologies), stained with the combinatorial MMr panels (9) detailed in figs. S7 and S10, and acquired using a BD FACSAria III cytometer. IFN- ELISpot assays were performed as described (7) . Single-cell gene expression analysis is detailed in fig. S9A and table S6.
Gene expression in human mTECs
Human thymus samples were obtained from children undergoing corrective cardiac surgery at the University of Heidelberg, Germany. mTECs were purified as described (13) . Sorted total, immature, and mature mTECs (CD45 − EpCAM + CDR2 − ) were independently validated for gene expression of the tissue-restricted Ags -casein and MelanA (13) . Amplified bands were sequenced to confirm identity with the expected SLC30A8 and INS regions. SLC30A8 exons were annotated with reference to Ensembl ID ENST00000427715. The INS PCR covered all INS transcripts except ENST00000512523 (product 1) and ENST00000421783 (product 2).
In situ ZnT8 186-194 MMr staining
In situ staining was performed as described (2) . Briefly, unfixed, frozen sections were dried for 2 hours, loaded with 1 g of MMrs overnight at 4°C, washed gently with phosphate-buffered saline, and fixed in 2% paraformaldehyde for 10 min. After a further wash, endogenous peroxidase activity was blocked with 0.3% H 2 O 2 . Sections were then incubated serially with rabbit anti-phycoerythrin, horseradish peroxidaseconjugated swine anti-rabbit, and 3,3′-diaminobenzidine tetrahydrochloride substrate (Thermo Fisher Scientific). After a final wash, sections were counterstained with hematoxylin, dehydrated via sequential passages in 95 to 100% ethanol and xylene, mounted, and analyzed using a Nikon Eclipse Ni microscope with NIS-Elements Analysis D software v4.40.
Statistical analysis
Data are shown as median (range) or mean ± SEM. Significance was assessed using two-tailed tests with a cutoff value of  = 0.05, as detailed for each figure. fig. S9A . Members of the ImMaDiab Study Group Data file S1. Raw data from figure graphs (Excel). Reference (43) 
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